Search This Blog

Tuesday, December 26, 2023

RBC says Bristol Myers/RayzeBio deal validates Fusion's approach

 RBC Capital sees Bristol Myers' acquisition of RayzeBio as providing external validation for Fusion Pharmaceuticals

https://seekingalpha.com/news/4050338-rbc-says-bristol-myersrayzebio-deal-validates-fusion-s-approach

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.